ASX:CTE

Cryosite Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume418 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive CTE News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryosite and its competitors with MarketBeat's FREE daily newsletter.

About Cryosite

Cryosite Limited engages in the supply chain logistics and management of pharmaceutical products used in clinical trials, and biological materials in Australia. It operates in two segments, Clinical Trials & Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials & Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, and biological storage services to the clinical trial and research industry. The Cord Blood and Tissues Storage segment offers long term storage for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. Cryosite Limited was founded in 1999 and is based in South Granville, Australia.

Cryosite Limited (ASX:CTE) Insider Bryan Dulhunty Purchases 1,300,000 Shares
September 7, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:CTE
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.cryosite.com
Phone61 2 8865 2000
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$10.02 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow0.55
Book ValueA$0.01 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.32 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cryosite.

4.9 Community Rank

Outperform Votes
Cryosite has received 11 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cryosite has received 4 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cryosite has received 73.33% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cryosite and other stocks. Vote “Outperform” if you believe CTE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CTE will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cryosite does not currently pay a dividend.
Dividend Growth
Cryosite does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cryosite insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$78,000.00 in company stock and sold A$0.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Cryosite (ASX:CTE) Frequently Asked Questions

What stocks does MarketBeat like better than Cryosite?: Wall Street analysts have given Cryosite a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cryosite wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are Cryosite's key executives?: Cryosite's management team includes the following people:
Mr. Bryan Dulhunty C.A., BEc, ACA, Non-Exec. Chairman & Company Sec.
Mr. Mark Edmund Payton Byrne, Chief Operating Officer of Fin. & Admin.
Mr. John Hogg, Chief Exec. Officer
Who are some of Cryosite's key competitors?: Some companies that are related to Cryosite include Australian Clinical Labs (ACL), BARD1 Life Sciences (BD1), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), dorsaVi (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures (GSS), Genetic Technologies (GTG), Imagin Medical (IME), Imagion Biosystems (IBX), Integral Diagnostics (IDX), Lifespot Health (LSH), Med BioGene (MBGNF) and Medical Imaging (MEDD).
View all of CTE's competitors.
What is Cryosite's stock symbol?: Cryosite trades on the ASX under the ticker symbol "CTE."
How much money does Cryosite make?: Cryosite has a market capitalization of $0.00 and generates $10.02 million in revenue each year.
How many employees does Cryosite have?: Cryosite employs 18 workers across the globe.
What is Cryosite's official website?: The official website for Cryosite is www.cryosite.com.
How can I contact Cryosite?: The company can be reached via phone at 61 2 8865 2000.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.